Macular Degeneration Care in Saratoga Springs, NY
Age-related macular degeneration (AMD) is the leading cause of central vision loss in adults over 50 in the United States — but early detection and proactive monitoring can make a significant difference in preserving your sight. At Saratoga Vision in Saratoga Springs, NY, our optometrists provide thorough AMD screenings and ongoing care to help protect your central vision for the long term. Call (518) 587-5900 to schedule your macular degeneration evaluation.
Book OnlineWhat Is Macular Degeneration?
Macular degeneration is a deterioration of the macula — the small, central area of the retina responsible for sharp, detailed central vision. The macula allows us to see fine details needed for reading, recognizing faces, driving, and other tasks that require straight-ahead vision. When the macula is damaged or degenerates, the central visual field becomes blurry, distorted, or dark — while peripheral (side) vision typically remains intact.
Age-related macular degeneration (AMD) is by far the most common form and primarily affects adults over 50. It is estimated to affect millions of Americans and is a leading cause of severe vision impairment in older adults. There are two forms of AMD — dry and wet — with distinct characteristics and management approaches.
Types of Macular Degeneration
Dry AMD (Atrophic AMD)
Dry AMD is the most common form, accounting for approximately 80-90% of AMD cases. It occurs when the light-sensitive cells in the macula gradually break down and the tissue thins and atrophies over time. Tiny yellow deposits called drusen form beneath the retina as an early sign of dry AMD. Vision loss is typically gradual, and there is currently no approved treatment to reverse dry AMD — however, certain nutritional supplements (AREDS2 formulas) have been shown to slow progression in intermediate and advanced cases.
Wet AMD (Neovascular AMD)
Wet AMD, although less common, is responsible for the majority of severe vision loss from AMD. It occurs when abnormal blood vessels grow beneath the retina (a process called choroidal neovascularization) and leak fluid or blood into the macular tissue, causing rapid and significant central vision damage. Wet AMD can progress quickly and requires urgent treatment. Modern anti-VEGF injections (administered by a retinal specialist) can effectively slow or halt the growth of abnormal blood vessels and preserve vision in many patients.
Signs and Symptoms of AMD
Many patients with early AMD have no noticeable symptoms. As the disease advances, common signs include:
- Blurry or fuzzy central vision
- Straight lines appearing wavy or distorted (metamorphopsia)
- A dark, blurry, or empty spot in the center of vision
- Difficulty reading fine print, even with glasses
- Colors appearing less vivid or bright
- Needing brighter light for close-up tasks
- Difficulty recognizing faces
If you notice any of these symptoms, contact Saratoga Vision immediately at (518) 587-5900. Sudden worsening of central vision, particularly with distortion, may indicate conversion from dry to wet AMD — which requires urgent specialist care.
AMD Risk Factors
Certain factors are known to increase the risk of developing AMD:
- Age: Risk increases significantly after age 50 and is most common in those over 65
- Family history: Having a first-degree relative with AMD substantially increases risk
- Smoking: One of the strongest modifiable risk factors — smokers are significantly more likely to develop AMD
- Race: AMD is more common in Caucasians than in other racial groups
- Cardiovascular disease: Heart disease, high blood pressure, and high cholesterol are associated with elevated AMD risk
- Obesity: Being significantly overweight increases risk of progression from early to advanced AMD
- UV light exposure: Long-term exposure to UV light may contribute to retinal damage over time
AMD Monitoring and Management at Saratoga Vision
At Saratoga Vision, we include AMD screening as part of every comprehensive eye exam for patients over 50 and for younger patients with risk factors. Our AMD evaluations include:
- Dilated fundus examination to assess the retina and macula
- Optomap ultra-widefield digital retinal imaging for a detailed view of the retina — learn more about our Optomap imaging services
- Amsler grid testing for early detection of visual distortion
- Optical coherence tomography (OCT) imaging when indicated to assess retinal layer thickness
Patients diagnosed with AMD are placed on an appropriate monitoring schedule based on the severity of their condition. If wet AMD or rapid progression is detected, we will promptly coordinate a referral to a retinal specialist for timely intervention. We also counsel AMD patients on protective lifestyle measures including smoking cessation, sun protection, diet, and AREDS2 supplementation. Patients with diabetes should also be aware that diabetic retinopathy can co-exist with AMD and requires its own separate management. Call (518) 587-5900 to schedule your AMD evaluation today.
Frequently Asked Questions About Macular Degeneration
What is the difference between dry and wet macular degeneration?
Dry AMD is the more common form, characterized by gradual thinning of the macular tissue and the buildup of small deposits called drusen beneath the retina. Vision loss is slow and progressive. Wet AMD is less common but more aggressive — it involves the growth of abnormal blood vessels beneath the retina that leak fluid or blood, causing rapid central vision damage. Wet AMD can cause significant vision loss within weeks and requires prompt treatment with anti-VEGF injections administered by a retinal specialist.
Can macular degeneration be cured?
Currently, there is no cure for either form of AMD. However, the progression of both dry and wet AMD can be managed. For intermediate and advanced dry AMD, AREDS2 vitamin supplements have been shown to reduce the risk of progression. Wet AMD is now effectively treated with anti-VEGF injections, which can stabilize or even partially improve vision in many patients when started promptly. Regular monitoring at Saratoga Vision is essential for detecting any progression early.
Who is at risk for macular degeneration?
The primary risk factor is age — AMD most commonly affects adults over 50, with risk increasing significantly after 65. Other risk factors include a family history of AMD, smoking, cardiovascular disease, obesity, prolonged sun exposure, and Caucasian ancestry. Certain genetic variants also increase risk. If any of these apply to you, we recommend annual comprehensive eye exams at Saratoga Vision that include a macular health evaluation.
What does vision loss from macular degeneration look like?
AMD primarily affects central vision — the ability to see straight ahead with fine detail. Patients with AMD may notice a blurry or dark spot in the center of their vision, difficulty reading small text, and distortion that makes straight lines appear wavy (a symptom called metamorphopsia). Peripheral vision is usually preserved. An Amsler grid — a simple grid of intersecting lines — is a useful home monitoring tool that AMD patients can use to detect changes in their central vision between appointments.
How is macular degeneration detected?
AMD is detected through a dilated retinal exam, retinal imaging, and in some cases optical coherence tomography (OCT) that creates cross-sectional images of the retinal layers. At Saratoga Vision, we use Optomap ultra-widefield digital retinal imaging as part of our retinal imaging services to capture a detailed view of the retina and macula. Early AMD often has no symptoms, which is why regular exams are so critical for at-risk patients.
Can lifestyle changes slow macular degeneration?
Yes. There is strong evidence that certain lifestyle factors can reduce AMD risk and slow its progression. Quitting smoking is the single most impactful change a smoker can make to protect their macular health. Eating a diet rich in leafy green vegetables, fish, and antioxidants, maintaining a healthy weight, protecting your eyes from UV radiation with sunglasses, and managing cardiovascular risk factors all contribute to better retinal health. For patients with intermediate AMD, AREDS2 nutritional supplements are clinically proven to reduce the risk of progression.
How often should I be monitored if I have macular degeneration?
Monitoring frequency depends on the type and severity of your AMD. Patients with early dry AMD may be monitored annually, while those with intermediate AMD typically require more frequent visits — every 6 to 12 months. Wet AMD patients receiving treatment are seen much more frequently by both their retinal specialist and our team at Saratoga Vision. We will establish a personalized monitoring plan and coordinate specialist care as needed. Call us at (518) 587-5900 to discuss your situation.